Source: Frontiers in Pharmacology. Unidade: ICB
Subjects: TECIDO ADIPOSO, METFORMINA, GLICOSE, QUIMIOTERAPIA, CAMUNDONGOS, INSULINA
ABNT
BIONDO, Luana A. et al. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue. Frontiers in Pharmacology, v. 9, p. 1-10, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00452. Acesso em: 01 maio 2024.APA
Biondo, L. A., Batatinha, H. A., Souza, C. O. de, Teixeira, A. A. de S., Silveira, L. S., Alonso-Vale, M. I., et al. (2018). Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue. Frontiers in Pharmacology, 9, 1-10. doi:10.3389/fphar.2018.00452NLM
Biondo LA, Batatinha HA, Souza CO de, Teixeira AA de S, Silveira LS, Alonso-Vale MI, Oyama LM, Alves MJ, Seelaender MCL, Rosa Neto JC. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-10.[citado 2024 maio 01 ] Available from: https://doi.org/10.3389/fphar.2018.00452Vancouver
Biondo LA, Batatinha HA, Souza CO de, Teixeira AA de S, Silveira LS, Alonso-Vale MI, Oyama LM, Alves MJ, Seelaender MCL, Rosa Neto JC. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-10.[citado 2024 maio 01 ] Available from: https://doi.org/10.3389/fphar.2018.00452